Skip to main content
SpringerLink
Log in

Introduction

  • Chapter
  • First Online:
Handbook of Hepatitis C

  • 1077 Accesses

Abstract

In 2014, the scientific community celebrated the 25th anniversary of the discovery of the hepatitis C virus (HCV). Since the isolation of HCV, extensive progress has been made in the field, and a growing knowledge of the virus life cycle has led to the development of potent drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Feinstone SM, Kapikian AZ, Purcell RH, Alter HJ, Holland PV. Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med. 1975;292:767–770.

    Google Scholar 

  2. Alter HJ, Purcell RH, Shih JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med. 1989; 321:1494–500.

    Google Scholar 

  3. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989;244:359–362.

    Google Scholar 

  4. Houghton M. Discovery of the hepatitis C virus. Liver Int. 2009;29 (Suppl 1) :82–88.

    Google Scholar 

  5. Selvarajah S, Busch MP. Transfusion transmission of HCV, a long but successful road map to safety. Antivir Ther. 2012;17:1423–1429.

    Google Scholar 

  6. Dienstag JL, McHutchison JG. American Gastroenterological Association technical review on the management of hepatitis C. Gastroenterology. 2006;130:231–264.

    Google Scholar 

  7. Lohmann V, Körner F, Koch J, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science. 1999;285:110–113.

    Google Scholar 

  8. Bartosch B, Dubuisson J, Cosset FL. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med. 2003;197:633–642.

    Google Scholar 

  9. Wakita T, Pietschmann T, Kato T, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med. 2005;11:791–796.

    Google Scholar 

  10. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST, et al. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57:1333–1342.

    Google Scholar 

  11. World Health Organization. Hepatitis C. Fact sheet No 164. Available at: www.who.int/mediacentre/factsheets/fs164/en/ (2015). Accessed 27 Nov 2015.

  12. Centers for Disease Control and Prevention. Viral Hepatitis - Statistics and Surveillance. Disease Burden from Viral Hepatitis A, B, and C in the United States. Available at: www.cdc.gov/hepatitis/Statistics/index.htm (2013). Accessed 27 Nov 2015.

  13. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–171.

    Google Scholar 

  14. Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med. 2012;156:271–278.

    Google Scholar 

  15. Negro F, Alberti A. The global health burden of hepatitis C virus infection. Liver Int. 2011;31 (Suppl 2):1–3.

    Google Scholar 

  16. Frank C, Mohamed MK, Strickland GT, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 2000;355:887–891.

    Google Scholar 

  17. Bruggmann P, Berg T, Øvrehus AL, et al. Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat. 2014;21 (Suppl 1):5–33.

    Google Scholar 

  18. Saraswat V, Norris S, de Knegt RJ, et al. Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2. J Viral Hepat. 2015;22 (Suppl 1):6–25.

    Google Scholar 

  19. Cornberg M, Razavi HA, Alberti A, et al. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int. 2011l;31 (Suppl 2):30–60.

    Google Scholar 

  20. Smith DB, Bukh J, Kuiken C, et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology. 2014;59:318–327.

    Google Scholar 

  21. Simmonds P, Bukh J, Combet C, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology. 2005;42:962–973.

    Google Scholar 

  22. Messina JP, Humphreys I, Flaxman A, et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015;61:77–87.

    Google Scholar 

  23. Murphy DG, Sablon E, Chamberland J, Fournier E, Dandavino R, Tremblay CL, et al. Hepatitis C virus genotype 7, a new genotype originating from central Africa. J Clin Microbiol. 2015;53:967–972.

    Google Scholar 

  24. Murphy DG, Willems B, Deschênes M, Hilzenrat N, Mousseau R, Sabbah S. Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5’ untranslated region sequences. J Clin Microbiol. 2007;45:1102–1112.

    Google Scholar 

  25. Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, et al. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis. 1995;171:1607–1610.

    Google Scholar 

  26. Rubbia-Brandt L, Fabris P, Paganin S, et al. Steatosis affects chronic hepatitis C progression in a genotype specific way. Gut. 2004;53:406–412.

    Google Scholar 

  27. Wohnsland A, Hofmann WP, Sarrazin C. Viral determinants of resistance to treatment in patients with hepatitis C. Clin Microbiol Rev. 2007;20:23–38.

    Google Scholar 

  28. Alter HJ, Houghton M. Clinical Medical Research Award. Hepatitis C virus and eliminating post-transfusion hepatitis. Nat Med. 2000;6:1082–1086.

    Google Scholar 

  29. Fabrizi F. Hepatitis C virus infection and dialysis: 2012 update. ISRN Nephrol. 2012;2013:159760.

    Google Scholar 

  30. Pereira BJ, Milford EL, Kirkman RL, Levey AS. Transmission of hepatitis C virus by organ transplantation. N Engl J Med. 1991;325:454–460.

    Google Scholar 

  31. Ellingson K, Seem D, Nowicki M, Strong DM, Kuehnert MJ; Organ Procurement Organization Nucleic Acid Testing Yield Project Team. Estimated risk of human immunodeficiency virus and hepatitis C virus infection among potential organ donors from 17 organ procurement organizations in the United States. Am J Transplant. 2011;11:1201–1208.

    Google Scholar 

  32. Prüss-Ustün A, Rapiti E, Hutin Y. Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers. Am J Ind Med. 2005;48:482–490.

    Google Scholar 

  33. Wiessing L, Guarita B, Giraudon I, Brummer-Korvenkontio H, Salminen M, Cowan SA. European monitoring of notifications of hepatitis C virus infection in the general population and among injecting drug users (IDUs) - the need to improve quality and comparability. Euro Surveill. 2008;13:18884.

    Google Scholar 

  34. Harsch HH, Pankiewicz J, Bloom AS, et al. Hepatitis C virus infection in cocaine users--a silent epidemic. Community Ment Health J. 2000;36:225–233.

    Google Scholar 

  35. Wandeler G, Gsponer T, Bregenzer A, et al. Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic. Clin Infect Dis. 2012;55:1408–1416.

    Google Scholar 

  36. Terrault NA, Dodge JL, Murphy EL, et al. Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. Hepatology. 2013;57:881–889.

    Google Scholar 

  37. Vandelli C, Renzo F, Romanò L, et al. Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study. Am J Gastroenterol. 2004;99:855–859.

    Google Scholar 

  38. Kao JH, Liu CJ, Chen PJ, Chen W, Lai MY, Chen DS. Low incidence of hepatitis C virus transmission between spouses: a prospective study. J Gastroenterol Hepatol. 2000;15:391–395.

    Google Scholar 

  39. Yeung LT, King SM, Roberts EA. Mother-to-infant transmission of hepatitis C virus. Hepatology. 2001;34:223–229.

    Google Scholar 

  40. US Department of Health and Human Services. Centers for Disease Control and Prevention. Hepatitis C. Why Baby Boomers should get tested. Publication No. 220401. Avaiblable at www.cdc.gov/knowmorehepatitis/Media/PDFs/FactSheet-Boomers.pdf (2015). Accessed 28 Jan 2016.

  41. Economic Intelligence Unit. The Silent Pandemic: Tackling Hepatitis C with Policy Innovation. A report from the Economist Intelligence Unit. Available at: www.janssen.ie/sites/stage-janssen-ie.emea.cl.datapipe.net/files/The%20Silent%20Pandemic%20-%20Tackling%20Hepatitis%20C%20with%20Policy%20Innovation.pdf (2012). Accessed 27 Nov 2015.

  42. Su J, Brook RA, Kleinman NL, Corey-Lisle P. The impact of hepatitis C virus infection on work absence, productivity, and healthcare benefit costs. Hepatology. 2010;52:436–442.

    Google Scholar 

  43. Estes C, Abdel-Kareem M, Abdel-Razek W, et al. Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies. Aliment Pharmacol Ther. 2015;42:696–706.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, USA

    Nicolas Goossens

  2. Department of Clinical Pathology, Faculty of Medicine, Geneva University Hospitals, Geneva, Geneve, Switzerland

    Sophie Clément

  3. Geneva University Hospitals, Geneva, Geneve, Switzerland

    Francesco Negro

Authors
  1. Nicolas Goossens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sophie Clément
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francesco Negro
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA

    Nicolas Goossens

  2. University Hospitals and Faculty of Medi, Clinical Pathology, Geneva, Geneve, Switzerland

    Sophie Clément

  3. Division of Gastroenterology and Hepatol, Geneva University Hospital, Geneva 14, Geneve, Switzerland

    Francesco Negro

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Goossens, N., Clément, S., Negro, F. (2016). Introduction. In: Goossens, N., Clément, S., Negro, F. (eds) Handbook of Hepatitis C . Adis, Cham. https://doi.org/10.1007/978-3-319-28053-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-28053-0_1

  • Published:

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-28051-6

  • Online ISBN: 978-3-319-28053-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation